Liver pathology in collagen vascular disorders highlighting the vascular changes within portal tracts

Indian Journal of Pathology and Microbiology

Volumn 54, Issue 1, 2011, Pages 25-31

  Vaiphei, Kim ^a,b   Bhatia, Alka ^a   Sinha, Saroj Kant ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE   (India)

Author keywords

Autoimmune hepatitis; collagen vascular disorders; nodular regenerative hyperplasia of liver; portal hypertension; portal vein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HYPERPLASIA; LIVER LEVEL; MALE; POLYARTERITIS NODOSA; PORTAL HYPERTENSION; PORTAL VEIN; RHEUMATOID ARTHRITIS; SEPTICEMIA; SEX; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 79952954058     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.77319     Document Type: Article

References (56)

1. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004;63:123-9. (Pubitemid 38124506)
2. Matsumoto T, Yoshimine T, Shimouchi K, Shiotu H, Kuwabara N, Fukuda Y, et al. The liver in systemic lupus erythematosus: Pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data. Hum Pathol 1992;23:1151-8.
3. Kojima H, Uemura M, Sakurai S, Ann T, Ishii Y, Imazu H, et al. Clinical features of liver disturbances in rheumatoid diseases: Clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol 2002;37:617-25.
4. Vergani D, Alvarez F, Bianchi FB, Canado EL, Mackay IR, Manns MP, et al. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-83. (Pubitemid 39297806)
5. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver: A clinicopathologic study of 30 cases. Hum Pathol 1981;12:60-71. (Pubitemid 12239395)
6. Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365-70. (Pubitemid 12012061)
7. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12.
8. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97. (Pubitemid 20191384)
9. Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, et al. Liver in collagen diseases: Pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000;20:366-73.
10. Oikawa H, Masuda T, Sato S, Yashima A, Suzuki K, Sato S, et al. Changes in lymph vessels and portal veins in the portal tract of patients with idiopathic portal hypertension: A morphometric study. Hepatology 1998;27:1607-10. (Pubitemid 28264686)
11. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005:11:627-34. (Pubitemid 40872900)
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498-502.
14. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93. (Pubitemid 20273292)
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
16. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease: Study of 593 patients. J Rheumatol 1989;16:328-34. (Pubitemid 19104571)
17. Nakanuma Y, Nonomura A, Hayashi M, Doishita K, Takayanagi N, Uchida T, et al. Pathology of the liver in "idiopathic portal hypertension" associated with autoimmune disease: The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee. Acta Pathol Jpn 1989;39:586-92. (Pubitemid 19253937)
18. Dubois EL, Tuffanelli DL. Clinical manifestations of SLE. JAMA 1964;190:104-11.
19. Rothfield NF. Systemic lupus erythematosus. Laboratory studies. Arthritis Rheum 1977;20:299-303.
20. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus: Report of 33 histologically proved cases and review of the literature. Am J Med 1980;69:187-94. (Pubitemid 10036815)
21. Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm 2002;59:S3-8. (Pubitemid 34142998)
22. Vermillion SE, Gregg JA, Baggenstoss AH, Bartholomew LG. Jaundice associated with bacteremia. Arch Intern Med 1969;124:611-8.
23. Pastor CM, Billiar TR, Losser MR, Payen DM. Liver injury during sepsis. J Crit Care 1995;10:183-97. (Pubitemid 26004512)
24. Banks JG, Foulis AK, Ledingham IM, Macsween RN. Liver function in septic shock. J Clin Pathol 1982;35:1249-52. (Pubitemid 13204006)
25. Koskinas J, Gomatos IP, Tiniakos DG, Memos N, Boutsikou M, Garatzioti A, et al. Liver histology in ICU patients dying from sepsis: A clinicopathological study. World J Gastroenterol 2008;14:1389-93. (Pubitemid 351425219)
26. van Hoek B.. The spectrum of liver disease in systemic lupus erythematosus. Neth J Med 1996;48:244-53. (Pubitemid 26184978)
27. Gibson T, Myers AR. Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 1981;8:752-9. (Pubitemid 12216373)
28. Miller MH, Urowitz MB, Gladman DD, Blendish LM. The liver in systemic lupus erythematosus. Q J Med 1984;53:401-9. (Pubitemid 14004820)
29. Mackay IR. Immunological perspectives on chronic hepatitis: Virus infection, autoimmunity and xenobiotics. Hepatogastroenterology 1999;46:3021-33.
30. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954;33:291-437.
31. Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol 2002;35:345-9.
32. Perez Ruiz F, Orte Martinez FJ, Zea Mendoza AC, Ruiz del Arbol L, Moreno Caparros A. Nodular regenerative hyperplasia of the liver in rheumatic diseases: Report of seven cases and review of the literature. Semin Arthritis Rheum 1991;21:47-54.
33. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematological disorders: A possible response to obliterative portal venopathy. Medicine (Baltimore) 1980;59:367-79.
34. Ranstrom S. Miliary hepatocellular adenomatosis. Acta Pathol Microbiol Scand 1953;33:225-9.
35. Wanless IR, Solt LC, Kortan P, Deck JH, Gardiner GW, Prokipchuk EJ. Nodular regenerative hyperplasia of the liver associated with macroglobulinemia: A clue to pathogenesis. Am J Med 1981;70:1203-9. (Pubitemid 11072113)
36. Okuda K. Non-cirrhotic portal hypertension versus idiopathic portal hypertension. J Gastroenterol Hepatol 2002;17Suppl 3 :S204-13. (Pubitemid 35454286)
37. Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis 2002;22:59-72.
38. Kondo F, Koshima Y, Ebara M. Nodular lesions associated with abnormal liver circulation. Intervirology 2004;47:277-87.
39. Kondo F, Nagao T, Sato T, Tomizawa M, Kondo Y, Matsuzaki O, et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 1998;194:487-95. (Pubitemid 28393713)
40. Dhiman RK, Chawla Y, Vashishta RK, Kakkar N, Dilawri JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002;17:6-16. (Pubitemid 34304381)
41. Sarin SK. Non-cirrhotic portal fibrosis. J Gastroenterol Hepatol 2002;17:S214-23. (Pubitemid 35454287)
42. Cadranel JF, Demontis R, Guettier C, Bouraya D, Dautreaux M, Ghazali A, et al. Nodular regenerative hyperplasia associated with antiphospholipid syndrome. Gastroentrol Clin Biol 1996;20:901-4. (Pubitemid 26366171)
43. Wanless IR, Albrecht S, Bilbao J, Frei JV, Heathcote EJ, Roberts EA, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: A new syndrome. Mod Pathol 1989;2:456-62.
44. Wanless IR. Epithelioid hemangioendothelioma, multiple focal nodular hyperplasias, and cavernous hemangiomas of the liver. Arch Pathol Lab Med 2000;124:1105-7. (Pubitemid 30650305)
45. Breiteneder - Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999;154:385-94. (Pubitemid 29094089)
46. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand Factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006;54:385-95.
47. Krasinskas AM, Goldsmith JD, Burke A, Furth EE. Abnormal intrahepatic portal vasculature in native and allograft liver biopsies: A comparative analysis. Am J Surg Pathol 2005;29:1382-8. (Pubitemid 41368775)
48. Ohbu M, Okudaira M, Watanabe K, Kaneko S, Takai T. Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension. Hepatology 1994;20:302-8. (Pubitemid 24233353)
49. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987;317:146-9. (Pubitemid 17092152)
50. Poirier TJ, Rankin GB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972;58:30-44.
51. Cohen S. The gastrointestinal manifestations of scleroderma: Pathogenesis and management. Gastroenterol 1980;79:155-66.
52. Bartholomew LG, Cain JC, Winkelmann RK, Baggenstoss AH. Chronic disease of the liver associated with systemic scleroderma. Am J Dig Dis 1964;9:43-55.
53. Ozcay N, Arda K, Sugunes T, Ozdemirel D, Aydoǧ G, Atalay F, et al. Polyarteritis nodosa presenting with necrotising appendicitis and hepatic aneurysm rupture. Turk J Gastroenterol 2003;14:68-70. (Pubitemid 36569850)
54. Wallace DJ. Gastrointestinal and hepatic manifestations. In: Wallace DJ, Hahn BH, editors. Dubois' Lupus Erythematosus. 5th ed. Baltimore: Williams and Wilkins; 1993. p. 835-50.
55. Chen J. Liver, gall bladder and pancreas. In: Liu TH, Liu TH, Li WH, editors. Diagnostic pathology. Beijing: People Health Press; 1995. p. 242.
56. Yoshimura M, Furutani AL, Konishi S, Sano Y, Tatsumi S, Yamaguchi M, et al. Normal weights of heart, liver and kidney in Japanese (1988 - 1992). Med J Kinki Univ 1994;19:297-302. (Japanese).